{"meta":{"query_hash":"2cadfb0a1b36","filters":{"venue":"Drugs - Real World Outcomes"},"cohort_total":41,"direct_labels_cover":0,"predictions_cover":41,"exported":41,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/2cadfb0a1b36","api":"https://metacan.xera.ac/api/v1/cohort?venue=Drugs+-+Real+World+Outcomes"},"results":[{"id":"W1267760291","doi":"10.1007/s40801-015-0032-7","title":"Medication Error Disclosure and Attitudes to Reporting by Healthcare Professionals in a Sub-Saharan African Setting: A Survey in Uganda","year":2015,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; African Population and Health Research Center; Health Resources and Services Administration; Fogarty International Center; International Development Research Centre; Wellcome Trust","keywords":"Medicine; Blame; Referral; Health professionals; Confidentiality; Family medicine; Health care; Nursing; Psychiatry","score_opus":0.12226231057865941,"score_gpt":0.4674734627165886,"score_spread":0.3452111521379292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1267760291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99942267,0.00012223035,0.000017098037,0.00013940946,0.0000018746803,0.000016443413,0.00004060344,6.5713647e-7,0.00023902439],"genre_scores_gemma":[0.9992291,0.00040283924,0.00008161483,0.00014885173,0.0000032996463,0.000026687643,0.00002472378,5.906131e-7,0.000082332714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978877,0.0010580574,0.00030488332,0.00011260455,0.0002860988,0.00035064924],"domain_scores_gemma":[0.99542445,0.0010884654,0.0022539303,0.00011685711,0.00045409266,0.0006621836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021415786,0.00021177428,0.00031645288,0.0011482845,0.0012881579,0.0009953167,0.00044663515,0.000620331,0.0011703639],"category_scores_gemma":[0.009078974,0.00062495645,0.00021324653,0.0013852629,0.00093086803,0.00084042357,0.0017084155,0.0006293979,0.00018395393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003882769,0.00008696745,0.96432364,0.00013802787,0.000015561816,0.0006739701,0.028839365,0.000021150228,0.00022360931,0.00003742236,0.00031757838,0.005283936],"study_design_scores_gemma":[0.000010524277,0.00029613293,0.9350678,0.00022377347,0.000013233298,0.0010070581,0.062046804,0.00012634318,0.00009214956,0.000031844822,0.0010700292,0.000014373572],"about_ca_topic_score_codex":0.017635077,"about_ca_topic_score_gemma":0.016736038,"teacher_disagreement_score":0.017635077,"about_ca_system_score_codex":0.0009546316,"about_ca_system_score_gemma":0.0015349919,"threshold_uncertainty_score":0.035064876},"labels":[],"label_agreement":null},{"id":"W1738852887","doi":"10.1007/s40801-015-0037-2","title":"Value Added by the Prevnar 13 Childhood Immunization Program in Alberta, Canada (2010–2015)","year":2015,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Institute of Health Economics","funders":"","keywords":"Medicine; Pneumococcal disease; Vaccination; Pneumococcal conjugate vaccine; Serotype; Incidence (geometry); Streptococcus pneumoniae; Disease burden; Meningitis; Immunization; Pediatrics; Public health; Immunization program; Environmental health; Demography; Immunology; Population; Antibiotics; Biology","score_opus":0.010603683428356292,"score_gpt":0.2755264871306302,"score_spread":0.26492280370227395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1738852887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4698697,0.028678542,0.0027706476,0.034120344,0.004319551,0.0006485403,0.27669743,0.0015454744,0.18134983],"genre_scores_gemma":[0.8429143,0.017932696,0.0064504277,0.0017247945,0.0005477981,0.00015640829,0.085481405,0.0001311925,0.044660956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972692,0.00022012425,0.00008030234,0.000108244065,0.0018289841,0.0004931428],"domain_scores_gemma":[0.9956267,0.00018014442,0.00028528346,0.00006083879,0.0030530102,0.0007939288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009885719,0.0007447202,0.00036572196,0.0034276685,0.0008128482,0.0022220386,0.0011159393,0.00053377805,0.007914634],"category_scores_gemma":[0.0062539657,0.00022181743,0.0006031431,0.0056178384,0.0004573268,0.00045800852,0.0011967795,0.00080211606,0.0010161918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004553944,0.000108802626,0.36265907,0.0010797193,0.00040784045,0.0006727385,0.00047616716,0.006552568,0.0006160988,0.002723848,0.31284255,0.3114053],"study_design_scores_gemma":[0.00009096406,0.00012122059,0.80420953,0.0009129653,0.0003438621,0.00035442325,0.001244225,0.0063264747,0.0006061822,0.0008251865,0.18490995,0.000055111177],"about_ca_topic_score_codex":0.9762998,"about_ca_topic_score_gemma":0.9793753,"teacher_disagreement_score":0.04593992,"about_ca_system_score_codex":0.04593992,"about_ca_system_score_gemma":0.074938565,"threshold_uncertainty_score":0.333319},"labels":[],"label_agreement":null},{"id":"W1948639110","doi":"10.1007/s40801-015-0036-3","title":"Polypharmacy Among the Elderly in a List-Patient System","year":2015,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"South East Regional Health Authority; Helsedirektoratet; Norges Forskningsråd; NAV","keywords":"Polypharmacy; Medicine; Medical prescription; Norwegian; Family medicine; Pharmacy; Population; Odds ratio; Quarter (Canadian coin); Medical emergency; Emergency medicine; Intensive care medicine; Internal medicine; Environmental health; Nursing","score_opus":0.08347578631348487,"score_gpt":0.3825228760703791,"score_spread":0.2990470897568942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1948639110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99539775,0.0002540305,0.00019724421,0.00013065999,0.000012975827,0.000031571446,0.003293765,0.0000093690005,0.0006726685],"genre_scores_gemma":[0.9955859,0.00024887614,0.00041642654,0.000120606004,0.000020794627,0.000041297353,0.003329929,0.0000035609694,0.00023257549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979091,0.0005538012,0.0004115203,0.00043196417,0.0004392703,0.00025430834],"domain_scores_gemma":[0.99035126,0.0012343451,0.006649607,0.0005885511,0.00058719824,0.00058902276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015818953,0.00016190017,0.0005445799,0.0010710694,0.0006178015,0.0010481193,0.0005119767,0.0003200135,0.0021603988],"category_scores_gemma":[0.0061803893,0.00033093328,0.00056141854,0.0022620824,0.00041781116,0.00096032716,0.0011258085,0.0004518593,0.00031865752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059285278,0.000049796297,0.9970784,0.000039152786,0.00003650141,0.00013980387,0.00018515636,0.000067897374,0.00005790773,0.00006208323,0.0005094681,0.0017146136],"study_design_scores_gemma":[0.000028527329,0.00011812899,0.99721473,0.000048923313,0.000048954305,0.00040383107,0.000535608,0.0004426018,0.000059958165,0.00010270461,0.0009875018,0.000008527435],"about_ca_topic_score_codex":0.045727577,"about_ca_topic_score_gemma":0.046927314,"teacher_disagreement_score":0.045727577,"about_ca_system_score_codex":0.0014798801,"about_ca_system_score_gemma":0.002019502,"threshold_uncertainty_score":0.09092283},"labels":[],"label_agreement":null},{"id":"W1993544540","doi":"10.1007/s40801-015-0017-6","title":"Supportive Care Costs Associated with Second-Line Chemotherapy in Chinese Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study","year":2015,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of Toronto","funders":"Eli Lilly and Company","keywords":"Pemetrexed; Docetaxel; Medicine; Oncology; Internal medicine; Chemotherapy; Lung cancer; Retrospective cohort study; Cisplatin","score_opus":0.005001315296113318,"score_gpt":0.27914570126479443,"score_spread":0.2741443859686811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993544540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994673,0.000102969,0.00003150991,0.000017088123,0.0000023811583,0.000012581452,0.0002790419,8.3392484e-7,0.00008641447],"genre_scores_gemma":[0.9992939,0.00008210157,0.00003761487,0.000017687547,0.00000512764,0.000016164753,0.00048660996,7.1833443e-7,0.0000600578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994211,0.00007582281,0.00010060384,0.00016265796,0.00013102344,0.0001087902],"domain_scores_gemma":[0.9985139,0.00010188778,0.000946668,0.0001357164,0.00013900839,0.00016286218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006007883,0.0003136873,0.00040885282,0.00094589073,0.0005772235,0.0005549981,0.00042930545,0.00036512676,0.00097428006],"category_scores_gemma":[0.0016475376,0.00030106894,0.0010251167,0.0017331344,0.0002730034,0.00040436676,0.00046767542,0.00045090576,0.000095076044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008974131,0.000018878844,0.9991949,0.000007337501,0.000094973024,0.000060906095,0.00002989177,0.00004144445,0.00005846449,0.000011444374,0.000039167782,0.0003528196],"study_design_scores_gemma":[0.000011687722,0.00007296026,0.99915266,0.0000039190536,0.00007034765,0.00018575879,0.00009775898,0.00022613193,0.000045077093,0.000011615406,0.000118202894,0.000003978326],"about_ca_topic_score_codex":0.02319303,"about_ca_topic_score_gemma":0.023161141,"teacher_disagreement_score":0.02319303,"about_ca_system_score_codex":0.0014672148,"about_ca_system_score_gemma":0.0011682248,"threshold_uncertainty_score":0.046116054},"labels":[],"label_agreement":null},{"id":"W2018210018","doi":"10.1007/s40801-015-0009-6","title":"Intravenous Immunoglobulin (IVIg) Utilization in Immune Thrombocytopenia (ITP): A Multi-Center, Retrospective Review","year":2015,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada); McMaster University; London Health Sciences Centre","funders":"Health Canada; GlaxoSmithKline; Terumo BCT; Canadian Blood Services; McMaster University; Amgen","keywords":"Medicine; Immune thrombocytopenia; Pediatrics; Retrospective cohort study; Antibody; Internal medicine; Immunology","score_opus":0.054446329133011964,"score_gpt":0.34734182709792744,"score_spread":0.2928954979649155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018210018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7631838,0.23135479,0.0003095267,0.00020615234,0.00003731853,0.00016147063,0.0034821203,0.000016182434,0.0012487131],"genre_scores_gemma":[0.9229643,0.07424532,0.00031064154,0.0002379265,0.00007853912,0.00012092075,0.0018920637,0.0000073600513,0.00014296973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974716,0.0003812416,0.0010160818,0.0004609099,0.00052141026,0.00014882903],"domain_scores_gemma":[0.9910122,0.0022233804,0.0053859614,0.00026477643,0.00089264003,0.00022104845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017106957,0.00027306037,0.0007191628,0.0041990546,0.0003990531,0.00095733907,0.00074145925,0.0004263265,0.0009428544],"category_scores_gemma":[0.0045972555,0.00038719198,0.00076463295,0.008347655,0.00045935804,0.0005595773,0.00045910367,0.0002225222,0.0001932784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016504199,0.000022665385,0.9785805,0.003952632,0.0005817623,0.0012361133,0.0002489207,0.000057428002,0.00024605094,0.00004618269,0.00072403415,0.014138672],"study_design_scores_gemma":[0.00003465434,0.0001684609,0.9797055,0.0031599363,0.0015671666,0.009029593,0.0008261248,0.00015640483,0.00029754394,0.000022418739,0.005011661,0.00002045599],"about_ca_topic_score_codex":0.017185003,"about_ca_topic_score_gemma":0.020651164,"teacher_disagreement_score":0.017185003,"about_ca_system_score_codex":0.0015491799,"about_ca_system_score_gemma":0.0021806497,"threshold_uncertainty_score":0.034169972},"labels":[],"label_agreement":null},{"id":"W2145274076","doi":"10.1007/s40801-015-0021-x","title":"4-Year Cost Trajectories in Real-World Patients Matched to the Metabolic Profiles of Trial Subjects Before/After Treatment with Phentermine-Topiramate","year":2015,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health","funders":"","keywords":"Phentermine; Medicine; Topiramate; Body mass index; Confidence interval; Randomized controlled trial; Internal medicine; Emergency department; Weight loss; Pediatrics; Obesity; Epilepsy; Psychiatry","score_opus":0.027093208706106434,"score_gpt":0.32468651156112277,"score_spread":0.29759330285501634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145274076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99857414,0.000060416638,0.00019350625,0.000046358615,0.0000029832356,0.000012582479,0.0010027362,0.0000027016524,0.00010467619],"genre_scores_gemma":[0.99608046,0.000047801932,0.00033796663,0.000028455532,0.000004793366,0.000026871745,0.0033730206,0.0000020195098,0.00009855098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885535,0.00046028037,0.00012256847,0.0003064836,0.00010776001,0.00014763488],"domain_scores_gemma":[0.9966654,0.0007363123,0.0018388832,0.00024813088,0.00021451627,0.00029673628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016687448,0.00035811885,0.0005692654,0.0007356653,0.00028174167,0.001025735,0.0004809941,0.0006217284,0.0009772768],"category_scores_gemma":[0.0062706717,0.0002673836,0.0010467103,0.0010582781,0.0003217824,0.0007886468,0.00058264396,0.00058122707,0.00019492238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015598215,0.00017350062,0.988117,0.000017852863,0.00039147882,0.00013062573,0.00006810373,0.0068953126,0.00015334816,0.00017717453,0.0002489274,0.0020670113],"study_design_scores_gemma":[0.00015073868,0.0009417691,0.96607924,0.000015895877,0.00016814559,0.00039121317,0.0002585295,0.030970871,0.00016984687,0.00035032924,0.00046880104,0.00003453285],"about_ca_topic_score_codex":0.012019926,"about_ca_topic_score_gemma":0.008510221,"teacher_disagreement_score":0.012019926,"about_ca_system_score_codex":0.0011738105,"about_ca_system_score_gemma":0.0005075756,"threshold_uncertainty_score":0.023899913},"labels":[],"label_agreement":null},{"id":"W2182795308","doi":"10.1007/s40801-015-0024-7","title":"Prevnar 7 Childhood Immunization Program and Serotype Replacement: Changes in Pneumococcal Incidence and Resulting Impact on Health Care Costs in Alberta (2003–2008)","year":2015,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; University of Calgary; University of Alberta; Institute of Health Economics","funders":"Pfizer Canada; Pfizer","keywords":"Pneumococcal conjugate vaccine; Vaccination; Serotype; Medicine; Immunization; Context (archaeology); Incidence (geometry); Environmental health; Pediatrics; Streptococcus pneumoniae; Immunology; Biology; Antibiotics; Immune system","score_opus":0.014291728036771673,"score_gpt":0.33948475761243396,"score_spread":0.3251930295756623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2182795308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907678,0.0010555602,0.00011914977,0.0009600647,0.000022679144,0.000024438537,0.0044603045,0.00002338721,0.0025666323],"genre_scores_gemma":[0.993451,0.00074057095,0.0002461646,0.00019221024,0.000021087135,0.000011393679,0.0036123917,0.000004712361,0.0017204756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993718,0.00007578409,0.000020490947,0.000044556986,0.00025663892,0.00023070636],"domain_scores_gemma":[0.9990496,0.00006478213,0.00028681077,0.000017483062,0.0003860013,0.00019533296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059004535,0.00042741912,0.00021330142,0.00090754876,0.0005616436,0.00088962173,0.00083392655,0.00043353208,0.0012024672],"category_scores_gemma":[0.0014417225,0.0001754954,0.000519977,0.0019921456,0.0004126006,0.00019816247,0.0004948145,0.0005530295,0.000093876864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005165352,0.00014692081,0.9725647,0.000080579535,0.00019180386,0.0004351069,0.00022099976,0.0064499667,0.0004023325,0.00039925845,0.0035742568,0.015017454],"study_design_scores_gemma":[0.000020964473,0.000038246,0.99733907,0.000015571632,0.000047960664,0.00007248823,0.00019766868,0.0013654561,0.00009799195,0.00003423262,0.00076454255,0.0000056599033],"about_ca_topic_score_codex":0.98391205,"about_ca_topic_score_gemma":0.9848905,"teacher_disagreement_score":0.030534046,"about_ca_system_score_codex":0.030534046,"about_ca_system_score_gemma":0.021585476,"threshold_uncertainty_score":0.22154105},"labels":[],"label_agreement":null},{"id":"W2241953676","doi":"10.1007/s40801-015-0048-z","title":"Efficacy of Low-Dose Oral Liquid Morphine for Elderly Patients with Chronic Non-Cancer Pain: Retrospective Chart Review","year":2015,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Dosing; Chronic pain; Opioid; Morphine; Retrospective cohort study; Rating scale; Demographics; Cancer; Physical therapy; Internal medicine","score_opus":0.018582633161282468,"score_gpt":0.30637145505932223,"score_spread":0.2877888218980398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2241953676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98736763,0.008118673,0.000298013,0.00009023341,0.00001631007,0.0005517757,0.0025159074,0.000014829528,0.0010266327],"genre_scores_gemma":[0.994762,0.0026721247,0.00046876541,0.00009926778,0.000027989057,0.00017173655,0.0016570117,0.0000041476837,0.00013693364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982886,0.00037044336,0.00058312726,0.00023353759,0.00040826786,0.000116043484],"domain_scores_gemma":[0.9877489,0.003168977,0.0065758736,0.00033964115,0.0017648007,0.00040165873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016365998,0.00019143312,0.0005694938,0.002364036,0.00044420143,0.0005255107,0.00046821043,0.00034833583,0.0010265118],"category_scores_gemma":[0.0050780033,0.00024631503,0.00047143025,0.00243586,0.00040950478,0.0004421251,0.0003311015,0.00026909352,0.00021510872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002293122,0.00007808877,0.98917973,0.00060127256,0.000084896754,0.002097938,0.00042184445,0.000045073404,0.00034164093,0.000023322684,0.00052112056,0.0063757943],"study_design_scores_gemma":[0.000039649534,0.0007357061,0.9897456,0.00029454145,0.00014310831,0.005797797,0.00090089976,0.0001354146,0.00039661655,0.000009759628,0.0017826176,0.000018166214],"about_ca_topic_score_codex":0.005972019,"about_ca_topic_score_gemma":0.009775338,"teacher_disagreement_score":0.005972019,"about_ca_system_score_codex":0.0010537605,"about_ca_system_score_gemma":0.0014869381,"threshold_uncertainty_score":0.011874557},"labels":[],"label_agreement":null},{"id":"W2347147152","doi":"10.1007/s40801-016-0071-8","title":"Accuracy of Adverse Drug Reaction Documentation upon Implementation of an Ambulatory Electronic Health Record System","year":2016,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Children's Hospital of Eastern Ontario","funders":"","keywords":"Documentation; Medicine; Ambulatory; Drug reaction; Electronic health record; Pharmacy; Health records; Health care; Medical emergency; Adverse drug reaction; Patient safety; Ambulatory care; Drug; Family medicine; Pharmacology; Internal medicine; Computer science","score_opus":0.0429544082367456,"score_gpt":0.4518422858514289,"score_spread":0.40888787761468326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2347147152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907392,0.0017578906,0.0032440808,0.0005644452,0.000058957867,0.00015932719,0.0013040325,0.000088645116,0.002083373],"genre_scores_gemma":[0.995342,0.00046223885,0.0031176256,0.000099815166,0.0000255448,0.00004634096,0.0007299198,0.000014092319,0.00016239144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.94964194,0.015578603,0.0168621,0.0025244486,0.014202299,0.0011907201],"domain_scores_gemma":[0.6578056,0.115701646,0.15437332,0.017289497,0.053226944,0.0016029654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03419897,0.0002190785,0.0005414846,0.002941281,0.00049373956,0.0018361404,0.001005573,0.0004677418,0.00072981627],"category_scores_gemma":[0.16521941,0.00029909034,0.00073191203,0.004193776,0.0005503081,0.0016163622,0.0015657701,0.0009519999,0.00023845735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018586109,0.000025366686,0.9775083,0.00020807279,0.00006241946,0.00010786246,0.0009834336,0.00027768724,0.00024184746,0.000055094377,0.0003116541,0.020032477],"study_design_scores_gemma":[0.000009347851,0.00022280814,0.9944918,0.0002994468,0.00007148219,0.00047464273,0.0008283223,0.0011489098,0.0009584692,0.000038857146,0.0014401649,0.000015650377],"about_ca_topic_score_codex":0.0058277724,"about_ca_topic_score_gemma":0.005060128,"teacher_disagreement_score":0.03419897,"about_ca_system_score_codex":0.0019203421,"about_ca_system_score_gemma":0.002254569,"threshold_uncertainty_score":0.18086362},"labels":[],"label_agreement":null},{"id":"W2387029624","doi":"10.1007/s40801-016-0073-6","title":"Persistence of Antipsychotic Treatment in Elderly Dementia Patients: A Retrospective, Population-Based Cohort Study","year":2016,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre; Canada Research Chairs; Institute for Clinical Evaluative Sciences; St. Michael's Hospital","funders":"Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences","keywords":"Antipsychotic; Persistence (discontinuity); Dementia; Retrospective cohort study; Medicine; Cohort; Psychiatry; Cohort study; Pediatrics; Internal medicine; Schizophrenia (object-oriented programming); Disease","score_opus":0.016298521895933765,"score_gpt":0.31258918932763985,"score_spread":0.29629066743170607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2387029624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985525,0.00025271482,0.00007171405,0.0000329909,0.000005575753,0.000026359541,0.00083183416,0.0000028018635,0.00022358012],"genre_scores_gemma":[0.9988631,0.00015012293,0.00009258239,0.00003703735,0.000008179032,0.000023062883,0.0007424851,0.000001819577,0.00008161443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882644,0.00021312418,0.00018132415,0.00031206253,0.0002838545,0.00018319265],"domain_scores_gemma":[0.9972428,0.00027984957,0.0013197309,0.00036658472,0.00038705405,0.0004040308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016177624,0.00035145922,0.00054776063,0.0011781675,0.0009788125,0.0010760269,0.00061679696,0.00064972293,0.0009396537],"category_scores_gemma":[0.0034731503,0.00054827065,0.0008650866,0.0021575873,0.00040387368,0.0007081635,0.0006133237,0.0008410264,0.00019890052],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008696719,0.000030009574,0.9993325,0.000005782034,0.00007835146,0.000048567712,0.000060903734,0.000011682191,0.00004384038,0.0000057526463,0.0000507611,0.00024486388],"study_design_scores_gemma":[0.000019740637,0.00013544975,0.9990403,0.000009132867,0.00007418326,0.0002416777,0.00020272964,0.000098585595,0.000019526455,0.000010988073,0.00014204613,0.0000056100503],"about_ca_topic_score_codex":0.051082958,"about_ca_topic_score_gemma":0.06039743,"teacher_disagreement_score":0.051082958,"about_ca_system_score_codex":0.0010228871,"about_ca_system_score_gemma":0.0013458149,"threshold_uncertainty_score":0.10157126},"labels":[],"label_agreement":null},{"id":"W2419833493","doi":"10.1007/s40801-014-0004-3","title":"Can 5-HT3 Antagonists Really Contribute to Serotonin Toxicity? A Call for Clarity and Pharmacological Law and Order","year":2014,"lang":"en","type":"editorial","venue":"Drugs - Real World Outcomes","topic":"Electroconvulsive Therapy Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Institute for Aging; University of Waterloo","funders":"","keywords":"CLARITY; Order (exchange); Serotonin; Serotonin syndrome; Law; Business; Medicine; Political science; Serotonergic; Biology; Internal medicine; Receptor","score_opus":0.011132724040600285,"score_gpt":0.33374048755938124,"score_spread":0.32260776351878095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419833493","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000068909634,0.023620246,0.00017115308,0.16609107,0.8088842,0.000020811178,0.000043912463,0.000038247766,0.0010614668],"genre_scores_gemma":[0.0008525156,0.0122854,0.00022707971,0.14643943,0.8363842,0.000038397586,0.000016705837,0.000029386172,0.0037269508],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9906516,0.0031161443,0.0016825927,0.00093339116,0.0032756722,0.0003404692],"domain_scores_gemma":[0.93813354,0.04605317,0.002686471,0.0010583895,0.010309444,0.0017590177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013269561,0.0024127855,0.0040970896,0.0027996541,0.0035257884,0.0054684835,0.0041667786,0.029238785,0.0040444112],"category_scores_gemma":[0.06372094,0.0012771331,0.0025379017,0.0018373303,0.0051613245,0.005959015,0.0015615796,0.025835263,0.0034718881],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041710813,0.000010358866,0.00003308966,0.00049701345,0.00003069421,0.00016003515,0.00005158842,0.00002444837,0.000032385215,0.00052121916,0.99271494,0.005882566],"study_design_scores_gemma":[0.00013823349,0.000066906585,0.0004439733,0.0028561922,0.00018807896,0.00065696327,0.00017191285,0.00024558257,0.00015530617,0.00523956,0.98979187,0.000045344455],"about_ca_topic_score_codex":0.0043869014,"about_ca_topic_score_gemma":0.0071917414,"teacher_disagreement_score":0.029238785,"about_ca_system_score_codex":0.005216972,"about_ca_system_score_gemma":0.005302853,"threshold_uncertainty_score":0.07017696},"labels":[],"label_agreement":null},{"id":"W2520348470","doi":"10.1007/s40801-016-0092-3","title":"Documentation of Functional Medication Management in Older Adults: A Retrospective Chart Review in Acute Care Hospitalization","year":2016,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Health Services","funders":"","keywords":"Medicine; Medical record; Retrospective cohort study; Documentation; Chart; Emergency medicine; Medication therapy management; Pediatrics; Pharmacy; Family medicine; Internal medicine","score_opus":0.02060814151626626,"score_gpt":0.3640180901953921,"score_spread":0.34340994867912583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520348470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989127,0.005899385,0.00038171076,0.00012595867,0.000026232907,0.0003465894,0.0029804662,0.000022880704,0.0010899057],"genre_scores_gemma":[0.99591535,0.0017325336,0.0005290493,0.00009386258,0.000026198199,0.00012803936,0.0014986402,0.0000038563303,0.000072475166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966625,0.00068665564,0.0012486107,0.0003856049,0.00078133226,0.00023535322],"domain_scores_gemma":[0.9823516,0.0030387456,0.011095073,0.0004443342,0.0023912904,0.0006789815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025500257,0.00023151639,0.0004720001,0.00399017,0.00058270193,0.00083290605,0.0005063887,0.0003382784,0.0007355234],"category_scores_gemma":[0.010018232,0.00032594413,0.00034871278,0.0037061435,0.0004165666,0.00068868423,0.0007192619,0.00034623084,0.0001292455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004007045,0.00002172066,0.99535865,0.00017329634,0.000030282317,0.0003153237,0.00041091052,0.000020580148,0.00008045958,0.000014582825,0.00036164385,0.0031724193],"study_design_scores_gemma":[0.0000071704735,0.00010998333,0.9964228,0.00024997248,0.000042894568,0.0010972734,0.0011528437,0.00008919787,0.00010755439,0.000008054848,0.00070535793,0.0000068741615],"about_ca_topic_score_codex":0.014488872,"about_ca_topic_score_gemma":0.02063911,"teacher_disagreement_score":0.014488872,"about_ca_system_score_codex":0.001374074,"about_ca_system_score_gemma":0.002001281,"threshold_uncertainty_score":0.02880907},"labels":[],"label_agreement":null},{"id":"W2552207502","doi":"10.1007/s40801-016-0097-y","title":"Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized β2-Agonists","year":2016,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; COPD; Hazard ratio; Internal medicine; Cohort; Retrospective cohort study; Confounding; Proportional hazards model; Confidence interval; Cohort study; Medical prescription; Pulmonary disease; Emergency medicine; Pharmacology","score_opus":0.021514996260417724,"score_gpt":0.3314830179196966,"score_spread":0.30996802165927884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552207502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991345,0.00045684061,0.000028364417,0.000026039626,0.000007655453,0.000011990565,0.0001646193,0.000001199104,0.00016883812],"genre_scores_gemma":[0.9993961,0.0001647411,0.000035782865,0.000027558031,0.000015525477,0.000012103253,0.00027473076,8.252564e-7,0.00007269082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990194,0.00031350166,0.00012940035,0.00020893035,0.00020358311,0.00012515245],"domain_scores_gemma":[0.99774724,0.0004804893,0.0010379207,0.00013395,0.00022838656,0.00037207498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011222739,0.00025802167,0.0006795653,0.0005623523,0.00030615958,0.0006454496,0.0004018132,0.0006150866,0.0013609217],"category_scores_gemma":[0.0036941424,0.00025781707,0.0011792352,0.0005930849,0.00015128899,0.0004287848,0.00042872413,0.0005402925,0.00016658731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019765145,0.00021126987,0.9950063,0.000040270334,0.00042170766,0.000057474826,0.00006435028,0.000038811424,0.00014569526,0.000017960097,0.000081905455,0.0019376217],"study_design_scores_gemma":[0.00011998699,0.0010456797,0.9979779,0.000014253027,0.00013802938,0.00014156217,0.00016635873,0.00023745827,0.000045919514,0.000012003695,0.00009628132,0.0000046254845],"about_ca_topic_score_codex":0.002053986,"about_ca_topic_score_gemma":0.0027759706,"teacher_disagreement_score":0.002053986,"about_ca_system_score_codex":0.00040494715,"about_ca_system_score_gemma":0.00034472518,"threshold_uncertainty_score":0.0059352517},"labels":[],"label_agreement":null},{"id":"W2760495556","doi":"10.1007/s40801-017-0116-7","title":"The Impact of US FDA and Health Canada Warnings Related to the Safety of High-dose Simvastatin","year":2017,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; Dalhousie University; Acadia University","funders":"Canadian Institutes of Health Research; Dalhousie University; Nova Scotia Health Research Foundation; Canadian Diabetes Association","keywords":"Simvastatin; Medicine; Environmental health; Pharmacology; Business","score_opus":0.011538709658854849,"score_gpt":0.3129625105223872,"score_spread":0.3014238008635324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760495556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652183,0.0039679147,0.0011029862,0.009994711,0.00014916524,0.00014974861,0.0052370713,0.000054984463,0.014125165],"genre_scores_gemma":[0.9969752,0.0006533862,0.00027970242,0.0007009817,0.00006824757,0.000011110508,0.00073790865,0.0000048987768,0.00056864816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9820593,0.0058821784,0.0013519961,0.00088116335,0.008711954,0.001113452],"domain_scores_gemma":[0.8575121,0.04067328,0.076338485,0.002924142,0.019449444,0.0031025468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012752084,0.0002323164,0.0004040882,0.0010313287,0.00061468955,0.0013479185,0.00076351926,0.00072820764,0.0028130382],"category_scores_gemma":[0.09381699,0.00025099862,0.0011395409,0.0019960904,0.00096937467,0.000509508,0.0010796527,0.0013303935,0.00018987396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011383686,0.00009589737,0.98013157,0.00014183314,0.00046184065,0.00007878912,0.00022042169,0.0014002139,0.00016840998,0.00022875222,0.0021753774,0.013758488],"study_design_scores_gemma":[0.000023097282,0.00016242175,0.99710315,0.000049631308,0.00012516233,0.000034523593,0.00010074633,0.0013023968,0.0001469749,0.000050077324,0.0008921605,0.000009561281],"about_ca_topic_score_codex":0.65110976,"about_ca_topic_score_gemma":0.57828397,"teacher_disagreement_score":0.65110976,"about_ca_system_score_codex":0.008310086,"about_ca_system_score_gemma":0.014963152,"threshold_uncertainty_score":0.7018899},"labels":[],"label_agreement":null},{"id":"W2789136834","doi":"10.1007/s40801-018-0130-4","title":"Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics","year":2018,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Paliperidone Palmitate; Paliperidone; Schizophrenia (object-oriented programming); Medicaid; Medicine; Psychiatry; Pediatrics; Antipsychotic; Health care; Economics","score_opus":0.01646006485359525,"score_gpt":0.3107103065546396,"score_spread":0.29425024170104436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789136834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986129,0.00037307388,0.000014082983,0.00021125637,0.0000052690652,0.000005866822,0.0005254927,8.2100166e-7,0.00025120066],"genre_scores_gemma":[0.99886644,0.00019112583,0.000029256307,0.000076214,0.000011772074,0.000007658357,0.00074823474,7.610541e-7,0.00006854764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993156,0.00018846126,0.00008788316,0.00007688507,0.00014267798,0.00018839979],"domain_scores_gemma":[0.99823356,0.00024178004,0.0010418738,0.000030815667,0.00009484835,0.00035712568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007353023,0.00017139463,0.00039051674,0.00063703,0.00047136395,0.0007482536,0.00028518957,0.00040685126,0.0013818357],"category_scores_gemma":[0.0037478982,0.00014139935,0.0012014351,0.0009488192,0.00022282879,0.0005314096,0.0008861013,0.0005577955,0.0000795932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006752384,0.000087694636,0.9954313,0.000017753324,0.00021300137,0.000093197996,0.00004794394,0.00023826875,0.0000729774,0.00005174749,0.00021216611,0.0028587154],"study_design_scores_gemma":[0.00004199755,0.00021065287,0.99810094,0.00003210852,0.00012044549,0.00014579759,0.00029233677,0.00080860965,0.000029131887,0.000043950095,0.00016891264,0.000005059583],"about_ca_topic_score_codex":0.030629337,"about_ca_topic_score_gemma":0.04121087,"teacher_disagreement_score":0.030629337,"about_ca_system_score_codex":0.0015670529,"about_ca_system_score_gemma":0.0011195979,"threshold_uncertainty_score":0.06090212},"labels":[],"label_agreement":null},{"id":"W2887337523","doi":"10.1007/s40801-018-0140-2","title":"Patient Understanding of the Neuropsychiatric Risks Associated with Branded Bupropion Hydrochloride Products Used for Smoking Cessation","year":2018,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International; GlaxoSmithKline","keywords":"Bupropion; Smoking cessation; Medicine; Medical prescription; Pharmacy; Referral; Cross-sectional study; Family medicine; Psychiatry; Pharmacology","score_opus":0.05718267092587089,"score_gpt":0.3134108455372867,"score_spread":0.25622817461141584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887337523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971963,0.00016049565,0.00011006913,0.0004217066,0.0000048787506,0.000044515145,0.00019669064,0.0000048333754,0.0018603551],"genre_scores_gemma":[0.998911,0.00019597082,0.00022453406,0.00019342556,0.0000072548387,0.00003646343,0.00011863151,9.143584e-7,0.00031178104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845266,0.000607684,0.00018792214,0.00010655305,0.00046738033,0.00017775455],"domain_scores_gemma":[0.99595827,0.0013440134,0.0017636548,0.00010613431,0.0004953517,0.000332604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00199508,0.0001273873,0.00024307313,0.00038027205,0.0003158775,0.0006546124,0.00020389515,0.0005317126,0.0051271333],"category_scores_gemma":[0.005945554,0.000117797485,0.0005067671,0.00019202745,0.00019961718,0.0004995279,0.0005210909,0.0007482397,0.00036810996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121743695,0.00033713714,0.9803807,0.00010533567,0.000067759785,0.00008532979,0.0019043082,0.00007582328,0.00059904426,0.00003176225,0.000577955,0.015713135],"study_design_scores_gemma":[0.00002092047,0.00065588957,0.9941765,0.00006987923,0.00005795341,0.00037937428,0.0026417305,0.00032808055,0.00028577622,0.000043658674,0.0013277965,0.000012392817],"about_ca_topic_score_codex":0.0021673816,"about_ca_topic_score_gemma":0.003157782,"teacher_disagreement_score":0.0051271333,"about_ca_system_score_codex":0.00030058713,"about_ca_system_score_gemma":0.0005315755,"threshold_uncertainty_score":0.017151952},"labels":[],"label_agreement":null},{"id":"W2954818983","doi":"10.1007/s40801-019-0156-2","title":"Re-evaluating Safety and Effectiveness of Dabigatran Versus Warfarin in a Nationwide Data Environment: A Prevalent New-User Design Study","year":2019,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Health and Welfare Data Science Center","keywords":"Dabigatran; Warfarin; Medicine; Hazard ratio; Atrial fibrillation; Cohort; Confidence interval; Medical prescription; Cohort study; Proportional hazards model; Retrospective cohort study; Internal medicine; Emergency medicine; Intensive care medicine; Pharmacology","score_opus":0.12881333431108558,"score_gpt":0.3932089206049435,"score_spread":0.26439558629385795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954818983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9683183,0.0028742733,0.019554228,0.00069049397,0.0003457757,0.0014331547,0.0051310197,0.000080016514,0.001572725],"genre_scores_gemma":[0.99077797,0.00022751505,0.0052581336,0.00044138564,0.00010951337,0.0006988955,0.0021414508,0.000022289385,0.00032292062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.8687434,0.10203739,0.010507454,0.008946387,0.008209619,0.001555779],"domain_scores_gemma":[0.80179596,0.078514874,0.043832004,0.058264505,0.013525513,0.004067153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.097917184,0.0007785848,0.0014079583,0.0015378256,0.0011610896,0.002202388,0.0021445274,0.0011830054,0.0027718775],"category_scores_gemma":[0.14817297,0.00069713494,0.0048722075,0.002194829,0.0011304579,0.0016348353,0.0022723672,0.0016345853,0.00047836246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00914425,0.0005507808,0.96433353,0.00040476004,0.0087247435,0.00018482376,0.00045776003,0.0006752921,0.00045787965,0.0007957219,0.001343286,0.012927245],"study_design_scores_gemma":[0.0051942426,0.018324077,0.9258168,0.00041357425,0.016565697,0.0014294332,0.00094018487,0.013304332,0.0025523435,0.0023432623,0.012943482,0.00017258254],"about_ca_topic_score_codex":0.0052482355,"about_ca_topic_score_gemma":0.0050636004,"teacher_disagreement_score":0.097917184,"about_ca_system_score_codex":0.001573145,"about_ca_system_score_gemma":0.0025547675,"threshold_uncertainty_score":0.51784176},"labels":[],"label_agreement":null},{"id":"W2989177796","doi":"10.1007/s40801-019-00164-9","title":"Comparison of Two Corticosteroid Pre-Infusion Regimens for Pegloticase in the United States: A Retrospective Analysis in Community Rheumatology Practices","year":2019,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Shores Centre for Mental Health Sciences","funders":"Horizon Therapeutics","keywords":"Medicine; Methylprednisolone; Corticosteroid; Hydrocortisone; Internal medicine; Rheumatology; Retrospective cohort study; Anesthesia","score_opus":0.03716421155932656,"score_gpt":0.4018806724597791,"score_spread":0.3647164609004525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989177796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850816,0.000844505,0.000050662034,0.00004239003,0.0000052762816,0.000022948692,0.00023802281,0.0000031089712,0.0002849866],"genre_scores_gemma":[0.9993924,0.00024754283,0.000043915865,0.000048319154,0.000007974998,0.000013788264,0.00021577877,0.0000024208261,0.00002787195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996384,0.0010098033,0.0006946718,0.00073606084,0.0007789083,0.00039657857],"domain_scores_gemma":[0.988698,0.0022454262,0.006693952,0.00039210482,0.000853122,0.0011174199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019393131,0.00035210964,0.00066556176,0.0019930026,0.0006113619,0.0011968822,0.00052086345,0.00082809414,0.0015730873],"category_scores_gemma":[0.006878886,0.0004853318,0.0008718088,0.0030324834,0.0006473199,0.0007670749,0.00079561386,0.00068167795,0.00024523312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020605708,0.00003882165,0.99851996,0.000015628906,0.00006683636,0.00007819031,0.00007470869,0.000015846379,0.000062398765,0.000007705884,0.000045316567,0.0008683882],"study_design_scores_gemma":[0.000028700302,0.00032776417,0.9981041,0.000022734705,0.0000710002,0.00052542466,0.00061430846,0.00009386348,0.000048294387,0.00000764836,0.0001495174,0.0000065711592],"about_ca_topic_score_codex":0.008211448,"about_ca_topic_score_gemma":0.008256782,"teacher_disagreement_score":0.008211448,"about_ca_system_score_codex":0.0010943203,"about_ca_system_score_gemma":0.0010171115,"threshold_uncertainty_score":0.016327262},"labels":[],"label_agreement":null},{"id":"W2991428633","doi":"10.1007/s40801-019-00172-9","title":"Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate","year":2019,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Paliperidone Palmitate; Paliperidone; Risperidone; Schizophrenia (object-oriented programming); Medicine; Psychiatry","score_opus":0.018422486526783688,"score_gpt":0.3094435811309784,"score_spread":0.29102109460419473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991428633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974285,0.00011653747,0.00013896603,0.00015713944,0.000006467389,0.000017980394,0.0019519742,0.000006182318,0.00017632986],"genre_scores_gemma":[0.99715084,0.00006170364,0.00025597046,0.00006413986,0.000010872544,0.000026406595,0.0023436025,0.0000025694162,0.000084049105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982931,0.0007980196,0.00017699055,0.0003431753,0.00018156433,0.00020719996],"domain_scores_gemma":[0.99293995,0.002025908,0.0033405034,0.00055678695,0.0004682398,0.00066868385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023874035,0.00035822383,0.00062800513,0.000641727,0.00040967445,0.0009113915,0.00057968905,0.0006331967,0.0018218219],"category_scores_gemma":[0.009765774,0.0003467093,0.0011460362,0.0011075321,0.0003311397,0.00056626735,0.0007741322,0.0010696964,0.00031854148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014765731,0.0005689298,0.9870863,0.00006585753,0.0005897906,0.00018382039,0.00014666934,0.0030501392,0.00017110514,0.00022881772,0.001510836,0.0049211592],"study_design_scores_gemma":[0.00024377606,0.00071805523,0.9706005,0.000045380235,0.00024394212,0.00028432655,0.0005544102,0.02595979,0.00013787042,0.0003774259,0.0007955886,0.00003890772],"about_ca_topic_score_codex":0.022551063,"about_ca_topic_score_gemma":0.01789965,"teacher_disagreement_score":0.022551063,"about_ca_system_score_codex":0.001299266,"about_ca_system_score_gemma":0.00083103904,"threshold_uncertainty_score":0.04483962},"labels":[],"label_agreement":null},{"id":"W3007537058","doi":"10.1007/s40801-020-00182-y","title":"Real-World Evidence to Assess Medication Safety or Effectiveness in Children: Systematic Review","year":2020,"lang":"en","type":"review","venue":"Drugs - Real World Outcomes","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Children's Hospital Research Institute of Manitoba; George & Fay Yee Centre for Healthcare Innovation; University of British Columbia","funders":"National Cancer Institute","keywords":"Observational study; Checklist; Medicine; Systematic review; Data extraction; Family medicine; Randomized controlled trial; MEDLINE; Pediatrics; Psychology; Surgery","score_opus":0.15401051938431068,"score_gpt":0.49016286220289157,"score_spread":0.33615234281858086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007537058","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014350556,0.9946885,0.00047974417,0.00060626,0.00019149327,0.0011727784,0.0008976423,0.000017493212,0.0005109934],"genre_scores_gemma":[0.04580473,0.9439224,0.003858601,0.001764952,0.00024377424,0.0033566144,0.0008983948,0.000016807946,0.00013379425],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.92860276,0.028524391,0.027812598,0.0031457092,0.010977771,0.0009367667],"domain_scores_gemma":[0.7281214,0.21659632,0.038294412,0.0044194176,0.011527014,0.0010414936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.050668888,0.0018683261,0.0096599655,0.016462546,0.0008992952,0.005143667,0.0032785768,0.002893568,0.005133697],"category_scores_gemma":[0.22151935,0.0017717673,0.010946576,0.015304085,0.0023782437,0.0055801,0.0027350853,0.0028344076,0.00044408627],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112836446,0.00001025803,0.0012727831,0.9721715,0.011901197,0.000050726503,0.00022425146,0.0000772866,0.000055292632,0.00025353892,0.00078675424,0.013083654],"study_design_scores_gemma":[0.00020539056,0.00010128925,0.0032661683,0.9417755,0.0452057,0.00014715071,0.00025146315,0.00008055677,0.00011500486,0.00039251454,0.008430644,0.000028599468],"about_ca_topic_score_codex":0.008808394,"about_ca_topic_score_gemma":0.024484033,"teacher_disagreement_score":0.050668888,"about_ca_system_score_codex":0.0068320646,"about_ca_system_score_gemma":0.023807697,"threshold_uncertainty_score":0.26796585},"labels":[],"label_agreement":null},{"id":"W3016701316","doi":"10.1007/s40801-020-00190-y","title":"Potentially Inappropriate Medication Use in Older Adults in the Preoperative Period: A Retrospective Study of a Noncardiac Surgery Cohort","year":2020,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Retrospective cohort study; Confidence interval; Incidence (geometry); Emergency medicine; Cohort; Emergency department; Cohort study; Population; Internal medicine","score_opus":0.0153736615623557,"score_gpt":0.2690336369461924,"score_spread":0.2536599753838367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016701316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991185,0.00023114023,0.000100337216,0.000025417294,0.00000505215,0.000019215386,0.00030493436,0.0000022705965,0.00019324337],"genre_scores_gemma":[0.9992225,0.000216615,0.00010709034,0.000051863495,0.000012365672,0.000022885724,0.000316091,0.0000019854026,0.000048523805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988985,0.00020159065,0.0002411206,0.00028704264,0.0002675664,0.000104145925],"domain_scores_gemma":[0.9971149,0.00030483116,0.0016355971,0.00028275096,0.00028458433,0.00037734213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013251556,0.0002957405,0.00047402893,0.0011590581,0.00059613754,0.0007020727,0.0003794171,0.00032236733,0.00086509116],"category_scores_gemma":[0.002814051,0.00044273093,0.00061530794,0.0014626476,0.0003644038,0.00075382,0.00063180714,0.00053690164,0.00020404764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020208556,0.000014250586,0.99941266,0.0000065568856,0.000024605011,0.000048781432,0.000067624016,0.000005296288,0.000051273226,0.0000043962746,0.000034208733,0.00031008385],"study_design_scores_gemma":[0.0000040989885,0.00008696643,0.9989912,0.000011204104,0.00002841772,0.00037281643,0.00029842116,0.000058485082,0.000025839612,0.0000067594756,0.00011256406,0.0000032058047],"about_ca_topic_score_codex":0.0068215965,"about_ca_topic_score_gemma":0.008268098,"teacher_disagreement_score":0.0068215965,"about_ca_system_score_codex":0.00036812137,"about_ca_system_score_gemma":0.0005619651,"threshold_uncertainty_score":0.013563812},"labels":[],"label_agreement":null},{"id":"W3030600181","doi":"10.1007/s40801-020-00200-z","title":"Knowledge and Understanding of the Safety and Efficacy Aspects of BRIDION® Among Canadian Anesthesiologists","year":2020,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"Merck Sharp and Dohme","keywords":"Sugammadex; Medicine; Rocuronium; American society of anesthesiologists; Patient safety; Anesthesia; Adverse effect; Confidence interval; Health care; Internal medicine; Propofol","score_opus":0.044904311703391216,"score_gpt":0.2857487695272452,"score_spread":0.240844457823854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030600181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98876977,0.000603334,0.000114438146,0.002673557,0.00001918006,0.000064069456,0.0005949391,0.0000063009265,0.007154438],"genre_scores_gemma":[0.9975279,0.0008933113,0.0001756832,0.00044677744,0.000009822914,0.000019932371,0.00025525872,0.0000017853491,0.0006694383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977857,0.00024264658,0.00014942694,0.0001288979,0.0012235206,0.00046982407],"domain_scores_gemma":[0.98936594,0.0022665984,0.002400587,0.00015364058,0.0038285218,0.0019847332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002148744,0.00017770378,0.00025797272,0.001100677,0.0017624762,0.0014259171,0.00060417847,0.00057809177,0.00453058],"category_scores_gemma":[0.014919343,0.00019089853,0.0004529918,0.0012127063,0.00090763095,0.0007417331,0.0007562638,0.0008264797,0.00022156294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089568195,0.00012145048,0.9486326,0.00025660556,0.000053320793,0.00019759868,0.019930847,0.00023330894,0.0003423173,0.00024043229,0.003576363,0.026325632],"study_design_scores_gemma":[0.0000130962735,0.00012034224,0.9790122,0.00025700618,0.000039823946,0.00011665471,0.015081147,0.00044818118,0.00011538738,0.000054629774,0.0047157025,0.000025882915],"about_ca_topic_score_codex":0.9336684,"about_ca_topic_score_gemma":0.92972136,"teacher_disagreement_score":0.066331625,"about_ca_system_score_codex":0.012081203,"about_ca_system_score_gemma":0.028309587,"threshold_uncertainty_score":0.13344449},"labels":[],"label_agreement":null},{"id":"W3038441428","doi":"10.1007/s40801-020-00204-9","title":"Risk of Adverse Cardiovascular Events Following a Myocardial Infarction in Patients Receiving Combined Clopidogrel and Proton Pump Inhibitor Treatment: A Nested Case–Control Study","year":2020,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Institute of Population and Public Health; University of Ottawa","funders":"Canadian Institutes of Health Research; University of Ottawa","keywords":"Clopidogrel; Myocardial infarction; Medicine; Nested case-control study; Internal medicine; Cardiology; Adverse effect; Proton-pump inhibitor; Case-control study","score_opus":0.008979068727267801,"score_gpt":0.2440145057981307,"score_spread":0.23503543707086288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038441428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99885297,0.0003487775,0.0003910603,0.000019384448,0.000013015667,0.000038257655,0.000101629455,0.0000035929029,0.00023131914],"genre_scores_gemma":[0.99924755,0.000096607575,0.00031117187,0.000026347194,0.000020901383,0.000031657997,0.00017467432,0.000002544125,0.00008864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774027,0.000675114,0.00019329802,0.0008590671,0.00039734718,0.00013486014],"domain_scores_gemma":[0.997621,0.0006045898,0.0006816363,0.00053188106,0.00029495478,0.0002659358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019466459,0.0004305265,0.00077272777,0.0006954598,0.0007412106,0.0008471442,0.00066004886,0.0007865042,0.0010884367],"category_scores_gemma":[0.0050834366,0.00078393915,0.0010153301,0.000635953,0.00054499763,0.00039130438,0.00054350955,0.0006639061,0.00020915712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016152579,0.0006185952,0.9917698,0.00004781795,0.0008697685,0.0008091068,0.00049952505,0.000065028384,0.0018310166,0.00008994599,0.00015765491,0.0016265275],"study_design_scores_gemma":[0.00031130138,0.0018992088,0.9911644,0.000028970922,0.00081326585,0.0032368677,0.0003113311,0.0009856448,0.00027924922,0.00010732515,0.00083596114,0.000026408783],"about_ca_topic_score_codex":0.0043210755,"about_ca_topic_score_gemma":0.003674549,"teacher_disagreement_score":0.0043210755,"about_ca_system_score_codex":0.0003528987,"about_ca_system_score_gemma":0.00035003526,"threshold_uncertainty_score":0.010294974},"labels":[],"label_agreement":null},{"id":"W3041049821","doi":"10.1007/s40801-020-00205-8","title":"Intravenous Lidocaine for Acute Pain: A Single-Institution Retrospective Study","year":2020,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Pediatric Pain Management Techniques","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"University of Ottawa","keywords":"Medicine; Analgesic; Anesthesia; Perioperative; Lidocaine; Retrospective cohort study; Opioid; Adverse effect; Surgery; Internal medicine","score_opus":0.025286709892683702,"score_gpt":0.3143450654071828,"score_spread":0.2890583555144991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041049821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965688,0.0019737736,0.0004231585,0.000065078726,0.000014001408,0.00011918711,0.0002617511,0.000008810011,0.00056548475],"genre_scores_gemma":[0.99823004,0.0009273091,0.00030162363,0.0001259068,0.000040288574,0.000063280575,0.00023909275,0.0000068050667,0.0000655156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971896,0.0005946843,0.0006905577,0.00063329324,0.00062883523,0.0002631098],"domain_scores_gemma":[0.9916333,0.0014860906,0.0047784434,0.0006642546,0.0007791598,0.0006587743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017781494,0.00040391218,0.00084042596,0.0019501993,0.00083022023,0.0013104172,0.0005531033,0.00062747806,0.0019914801],"category_scores_gemma":[0.005018754,0.0007240463,0.0006934402,0.0030410604,0.00072587817,0.0010862843,0.0008239277,0.00064201304,0.0005583988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010138191,0.00005810286,0.9973717,0.000051580464,0.00006605879,0.0007593346,0.00012274971,0.000017773718,0.00012851674,0.00002040431,0.000099600744,0.0012027998],"study_design_scores_gemma":[0.000080137535,0.0013397591,0.9748448,0.00022258177,0.00035499877,0.01851605,0.0022242104,0.0003638744,0.00028667285,0.00006717385,0.0016602755,0.000039494746],"about_ca_topic_score_codex":0.0020622576,"about_ca_topic_score_gemma":0.0026420977,"teacher_disagreement_score":0.0020622576,"about_ca_system_score_codex":0.0007970006,"about_ca_system_score_gemma":0.0011927031,"threshold_uncertainty_score":0.009403884},"labels":[],"label_agreement":null},{"id":"W3126347994","doi":"10.1007/s40801-020-00226-3","title":"Real-World Utilization and Safety of Daratumumab IV Rapid Infusions Administered in a Community Setting: A Retrospective Observational Study","year":2021,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Daratumumab; Medicine; Regimen; Adverse effect; Internal medicine; Emergency medicine; Multiple myeloma","score_opus":0.11842715844150209,"score_gpt":0.40153267830723555,"score_spread":0.28310551986573346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126347994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986303,0.00047775652,0.00013192178,0.00003816226,0.000004564287,0.00005011266,0.00040928935,0.00000286484,0.00025508864],"genre_scores_gemma":[0.99903464,0.00024177131,0.00013899444,0.000077402205,0.000011952253,0.000044945577,0.00041551236,0.000002750463,0.000032175052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99680907,0.0009887476,0.00057492545,0.00071860367,0.00057952444,0.0003291875],"domain_scores_gemma":[0.9889846,0.0015775864,0.0071048154,0.00062322494,0.0009030274,0.000806678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022845622,0.00033191373,0.0006669028,0.0013722961,0.00064616173,0.0011099228,0.00055798166,0.0006925374,0.0013018152],"category_scores_gemma":[0.0071106614,0.000519943,0.0008115313,0.0024679983,0.00057420577,0.000978882,0.00081092765,0.00092316384,0.00023958176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018440706,0.00009313967,0.9981458,0.000054589695,0.000103709586,0.00010506737,0.00015379014,0.000029016019,0.000082691666,0.0000139299,0.00010293451,0.00093100016],"study_design_scores_gemma":[0.000059542203,0.00072668045,0.99596405,0.00008227856,0.00015826912,0.0009294003,0.0010198868,0.0003902829,0.00008248346,0.000028086557,0.0005399751,0.000019064726],"about_ca_topic_score_codex":0.006041334,"about_ca_topic_score_gemma":0.005235329,"teacher_disagreement_score":0.006041334,"about_ca_system_score_codex":0.00088131137,"about_ca_system_score_gemma":0.0010852732,"threshold_uncertainty_score":0.01208204},"labels":[],"label_agreement":null},{"id":"W3165358711","doi":"10.1007/s40801-021-00257-4","title":"Factors Associated with Hyponatremia in Patients Newly Prescribed Citalopram: A Retrospective Observational Study","year":2021,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Electrolyte and hormonal disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hotchkiss Brain Institute; Calgary Laboratory Services; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Observational study; Hyponatremia; Citalopram; Retrospective cohort study; Medicine; Emergency medicine; Intensive care medicine; Internal medicine; Antidepressant","score_opus":0.055434970195858455,"score_gpt":0.30272618785623606,"score_spread":0.2472912176603776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165358711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989807,0.0002949225,0.00006831322,0.000029977047,0.0000055708183,0.000016824486,0.00041064539,0.0000019701008,0.0001910114],"genre_scores_gemma":[0.999097,0.00021766474,0.000076558055,0.000038945753,0.00001209887,0.000015158603,0.0004979457,0.0000013230316,0.000043192067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912506,0.00015654531,0.00013765245,0.00022353536,0.00023175184,0.00012542594],"domain_scores_gemma":[0.99734926,0.00034176544,0.0015619489,0.00019338209,0.0002306317,0.00032299935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009611877,0.000284071,0.00053637504,0.00081027264,0.0006044158,0.0007821006,0.0004817595,0.00040273834,0.0009638163],"category_scores_gemma":[0.0022536714,0.00050667214,0.0007430005,0.0019673991,0.00033190267,0.0006094934,0.00049322285,0.0007319427,0.00015451005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004093484,0.000014223716,0.9996138,0.0000071423797,0.000032212865,0.00004512139,0.000031224794,0.000008899413,0.000037833484,0.00000446591,0.000031367606,0.00013281024],"study_design_scores_gemma":[0.000011499273,0.000093549206,0.9989329,0.000010039471,0.000052544954,0.00038859269,0.00020985157,0.00012598233,0.000021365497,0.0000087656645,0.00014053208,0.0000044158196],"about_ca_topic_score_codex":0.013333646,"about_ca_topic_score_gemma":0.017674979,"teacher_disagreement_score":0.013333646,"about_ca_system_score_codex":0.00070965145,"about_ca_system_score_gemma":0.0010813402,"threshold_uncertainty_score":0.026512086},"labels":[],"label_agreement":null},{"id":"W3199290955","doi":"10.1007/s40801-021-00275-2","title":"Reporting Rates of Opioid-Related Adverse Events Since 1965 in Canada: A Descriptive Retrospective Study","year":2021,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Université Laval; Centre Hospitalier Universitaire Sainte-Justine; Institut universitaire de cardiologie et de pneumologie de Québec; Université du Québec à Trois-Rivières","funders":"Health Canada; Université du Québec à Trois-Rivières","keywords":"Medicine; Confidence interval; Opioid; Oxycodone; Retrospective cohort study; Adverse effect; Population; Internal medicine; Demography; Emergency medicine; Environmental health","score_opus":0.01950930977869455,"score_gpt":0.3021075079206801,"score_spread":0.28259819814198556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199290955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778441,0.002500398,0.00022863185,0.0002275373,0.00001712111,0.00011163771,0.016206801,0.00003164411,0.0028321538],"genre_scores_gemma":[0.99271023,0.0018987526,0.00023601709,0.0001376833,0.000010069183,0.000033869892,0.0044887722,0.000010361069,0.00047435486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850625,0.00006958952,0.00021466913,0.00027006344,0.0006274644,0.00031205267],"domain_scores_gemma":[0.9945687,0.00028675125,0.0022802807,0.00017939747,0.002039478,0.00064540264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007559367,0.0003134879,0.00044777448,0.0029461726,0.0017600743,0.0012302686,0.0010625487,0.00038977552,0.0018649333],"category_scores_gemma":[0.0028711653,0.00044498846,0.0006289635,0.0077325227,0.0007419816,0.00048650044,0.0008213847,0.0007074265,0.00025950218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023644056,0.000010354611,0.9980805,0.00004706134,0.000033234603,0.000057233214,0.00021201177,0.000032630443,0.00004539427,0.000022662862,0.0003302313,0.0011049638],"study_design_scores_gemma":[0.0000018549855,0.000016900012,0.9983974,0.000040215902,0.000025866178,0.00014174476,0.0005322929,0.00008901219,0.00004277638,0.000006522933,0.00069734635,0.000008179321],"about_ca_topic_score_codex":0.96896076,"about_ca_topic_score_gemma":0.9619555,"teacher_disagreement_score":0.031039238,"about_ca_system_score_codex":0.014177296,"about_ca_system_score_gemma":0.018795524,"threshold_uncertainty_score":0.10286397},"labels":[],"label_agreement":null},{"id":"W3200732477","doi":"10.1007/s40801-021-00271-6","title":"Human Papillomavirus Vaccination and Premature Ovarian Failure: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System","year":2021,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Università degli Studi di Siena","keywords":"Adverse Event Reporting System; Premature ovarian failure; Medicine; Vaccination; Adverse effect; Confidence interval; Gynecology; Internal medicine; Immunology","score_opus":0.03294950474255445,"score_gpt":0.37821174005284136,"score_spread":0.3452622353102869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200732477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98030317,0.0022144846,0.006125226,0.00037989725,0.000044952132,0.00057565403,0.009269411,0.000081624705,0.0010055673],"genre_scores_gemma":[0.9922782,0.00034239484,0.0027309177,0.00005932004,0.000050171573,0.0004049618,0.004013374,0.000020637493,0.00010004498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9403917,0.028625304,0.015814446,0.006481914,0.007139805,0.0015469469],"domain_scores_gemma":[0.8407133,0.08187225,0.06181491,0.008335775,0.0057220636,0.0015416972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.039742526,0.00057970674,0.0011286084,0.013319408,0.0006475084,0.0018337177,0.0011075009,0.0006254027,0.00234309],"category_scores_gemma":[0.10194168,0.00044930732,0.004890383,0.01168571,0.00073862704,0.002176486,0.0032695245,0.0009923299,0.0004191056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019689911,0.000023624747,0.9952095,0.00018902222,0.0007240775,0.000055749144,0.00013271677,0.00019860243,0.00008476475,0.00008326394,0.00022787217,0.0028738708],"study_design_scores_gemma":[0.000029249344,0.00026651207,0.9907449,0.00017991931,0.0006830524,0.0005875219,0.0004910877,0.0054945108,0.00025481055,0.00019300592,0.00104105,0.000034356548],"about_ca_topic_score_codex":0.0048304596,"about_ca_topic_score_gemma":0.0025631215,"teacher_disagreement_score":0.039742526,"about_ca_system_score_codex":0.0009106242,"about_ca_system_score_gemma":0.0011928998,"threshold_uncertainty_score":0.21018112},"labels":[],"label_agreement":null},{"id":"W3204439060","doi":"10.1007/s40801-021-00280-5","title":"Anti-Epileptic Medication Exposure Influences Functional Status in New Zealand Stroke Patients: A Retrospective Population-Level Study","year":2021,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Research Canada; Simon Fraser University","funders":"","keywords":"Medicine; Stroke (engine); Odds ratio; Confidence interval; Body mass index; Cohort; Cohort study; Population; Internal medicine; Physical therapy; Pediatrics; Environmental health","score_opus":0.018007411772964627,"score_gpt":0.28405288725561684,"score_spread":0.2660454754826522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204439060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977731,0.00037315264,0.00008812203,0.00006607139,0.0000063811526,0.000043075022,0.0012163058,0.0000041609132,0.00042949052],"genre_scores_gemma":[0.99845684,0.00031771188,0.00012252963,0.000044442084,0.0000086423925,0.00004643157,0.0008954978,0.0000031844504,0.0001045765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984463,0.0002472531,0.00030825185,0.0004061886,0.00039830388,0.00019378634],"domain_scores_gemma":[0.9970354,0.00020923374,0.0016977512,0.00032139293,0.00040690147,0.00032938155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012842317,0.0005010045,0.0007590674,0.001162142,0.00069732533,0.0011273876,0.00078069285,0.00062303134,0.0014874126],"category_scores_gemma":[0.004470811,0.0007256621,0.0010915799,0.0029163377,0.0007964187,0.00091056863,0.000990047,0.0009146729,0.00031620893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007076964,0.000019952911,0.99877006,0.000024794599,0.00014013433,0.00007208751,0.00016836867,0.000015396932,0.00011704039,0.000008021052,0.00008833096,0.00050512125],"study_design_scores_gemma":[0.000008566804,0.000039579274,0.9994024,0.000007706107,0.000045766617,0.00011860614,0.0001584018,0.000047962636,0.0000112007765,0.0000067408164,0.00014854143,0.0000044975777],"about_ca_topic_score_codex":0.18345496,"about_ca_topic_score_gemma":0.15108998,"teacher_disagreement_score":0.18345496,"about_ca_system_score_codex":0.0016210536,"about_ca_system_score_gemma":0.0015865655,"threshold_uncertainty_score":0.3647743},"labels":[],"label_agreement":null},{"id":"W32617885","doi":"10.1007/s40801-020-00204-9","title":"Gerenciamento de cadeias de suprimentos: análise da avaliação de desempenho de uma cadeia de carne e produtos industrializados de frango no Brasil","year":2003,"lang":"pt","type":"dissertation","venue":"Drugs - Real World Outcomes","topic":"Rural Development and Agriculture","field":"Environmental Science","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Ottawa","keywords":"Humanities; Art","score_opus":0.017382361549249596,"score_gpt":0.28059179141136814,"score_spread":0.26320942986211854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W32617885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99678516,0.000984974,0.00015186465,0.00011781726,0.0000039406805,0.00002062663,0.00034246568,0.000004886851,0.0015883344],"genre_scores_gemma":[0.9989706,0.0004833821,0.00024484782,0.000018297384,0.0000038553776,0.0000075366374,0.000090337635,0.0000016174749,0.00017949205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923646,0.00024000145,0.00007189847,0.00013398525,0.00023013676,0.00008743632],"domain_scores_gemma":[0.99686396,0.0007974826,0.0014736577,0.00026875667,0.00041106142,0.00018512519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013972543,0.00021957998,0.00036607686,0.0015356212,0.0003623829,0.00077485986,0.00038642815,0.0004771427,0.001216705],"category_scores_gemma":[0.006351726,0.00025078192,0.00046172246,0.0017622119,0.00058173446,0.0004621802,0.00036273964,0.0003129161,0.00013837806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026254603,0.000030017272,0.9829867,0.00011779941,0.00009686756,0.00010537752,0.0016827023,0.00004883342,0.0010454301,0.00013637137,0.00008647287,0.0134008145],"study_design_scores_gemma":[0.000004065153,0.00012465725,0.9981041,0.000024721207,0.00007851664,0.00017716625,0.0006385437,0.00008838452,0.0002656683,0.000075392585,0.00041257535,0.0000060188827],"about_ca_topic_score_codex":0.030904278,"about_ca_topic_score_gemma":0.044887148,"teacher_disagreement_score":0.030904278,"about_ca_system_score_codex":0.0005586346,"about_ca_system_score_gemma":0.0007437769,"threshold_uncertainty_score":0.061448812},"labels":[],"label_agreement":null},{"id":"W4280628955","doi":"10.1007/s40801-022-00297-4","title":"Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study","year":2022,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ministry of Health; University of Manitoba","funders":"University of Manitoba","keywords":"Paliperidone; Medical prescription; Risperidone; Medicine; Dosing; Medical record; Pharmacoepidemiology; Confidence interval; Pediatrics; Demography; Internal medicine; Schizophrenia (object-oriented programming); Psychiatry; Pharmacology","score_opus":0.06347471143503726,"score_gpt":0.3711131617465185,"score_spread":0.30763845031148124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280628955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938083,0.00017761748,0.001513403,0.00008246237,0.0000135812525,0.00064137724,0.00316148,0.00001840072,0.0005834076],"genre_scores_gemma":[0.9844118,0.00014191378,0.0035677617,0.00014686894,0.000027804044,0.00052100304,0.010994837,0.000016676884,0.00017137558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9839504,0.006530873,0.0018825604,0.0017627323,0.005161163,0.0007122812],"domain_scores_gemma":[0.87772524,0.0489935,0.03034072,0.016691132,0.023718877,0.002530493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.034191824,0.00064315856,0.00054902217,0.0020424537,0.0009540629,0.0015709859,0.0015377384,0.00091590214,0.0012415408],"category_scores_gemma":[0.08025241,0.00042284312,0.001320855,0.0025014908,0.0011556724,0.0010807449,0.0014562177,0.0009167748,0.0006585217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051266875,0.00054986146,0.9919525,0.00013416827,0.00027149013,0.000116052404,0.0006246733,0.00029826091,0.00037191136,0.00012437385,0.0005085956,0.004535479],"study_design_scores_gemma":[0.00026153654,0.0007636795,0.9873239,0.000264054,0.00032471237,0.00061071286,0.00064994395,0.0063259895,0.00081732863,0.00009399588,0.0025285538,0.00003565606],"about_ca_topic_score_codex":0.028457586,"about_ca_topic_score_gemma":0.02772977,"teacher_disagreement_score":0.034191824,"about_ca_system_score_codex":0.0021317708,"about_ca_system_score_gemma":0.005428485,"threshold_uncertainty_score":0.18082583},"labels":[],"label_agreement":null},{"id":"W4295900086","doi":"10.1007/s40801-022-00329-z","title":"Impact of the COVID-19 Pandemic on Patterns of Prescription Opioid Use: A Retrospective Cohort Study of Adults Without a Cancer Diagnosis Initiating Opioids Using Administrative Claims Data","year":2022,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Inro Consultants (Canada)","funders":"","keywords":"Medicine; Medical prescription; Opioid; Pandemic; Retrospective cohort study; Emergency medicine; Young adult; Confidence interval; Coronavirus disease 2019 (COVID-19); Internal medicine; Disease; Pharmacology","score_opus":0.11710455460969481,"score_gpt":0.4251857775077892,"score_spread":0.30808122289809436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295900086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700147,0.00016120913,0.00009933265,0.000063565494,0.000006362144,0.000035118133,0.0024050209,0.0000036881677,0.000224213],"genre_scores_gemma":[0.99819225,0.00008448906,0.00010536988,0.00006230023,0.00000702562,0.000024012235,0.0014168753,0.0000023463097,0.00010532537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840444,0.00025218143,0.00021544112,0.00044472254,0.0003637225,0.0003194665],"domain_scores_gemma":[0.99574345,0.00040464962,0.002078967,0.00047251952,0.00064524036,0.0006551424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017678678,0.00047723026,0.00046978076,0.00089044904,0.0010713266,0.0012048136,0.0010143617,0.00067404046,0.0012209556],"category_scores_gemma":[0.0041550305,0.00057116756,0.0009947224,0.002140525,0.0004958419,0.00063902757,0.00092621887,0.0011490488,0.00023020669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031595777,0.000016457976,0.99956495,0.000003925486,0.00004184818,0.000017930679,0.00005939754,0.000017066795,0.000026483076,0.0000060551693,0.00006847034,0.00014578046],"study_design_scores_gemma":[0.0000052632377,0.00004834245,0.9991479,0.000009773068,0.000025554029,0.0000645606,0.0002830801,0.00026187795,0.000017991768,0.0000056526646,0.00012515948,0.0000047291346],"about_ca_topic_score_codex":0.44077614,"about_ca_topic_score_gemma":0.42750934,"teacher_disagreement_score":0.44077614,"about_ca_system_score_codex":0.002520518,"about_ca_system_score_gemma":0.003012176,"threshold_uncertainty_score":0.8764211},"labels":[],"label_agreement":null},{"id":"W4306313907","doi":"10.1007/s40801-022-00326-2","title":"Clinical Characteristics of Registry Participants with Psoriatic Arthritis Initiating Guselkumab: An Analysis from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry","year":2022,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Janssen Scientific Affairs","keywords":"Psoriatic arthritis; Medicine; Dermatology; Psoriasis; Arthritis; Internal medicine","score_opus":0.035656069188317964,"score_gpt":0.33169489355779613,"score_spread":0.29603882436947815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306313907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99440336,0.0002220957,0.00010677589,0.000036331305,0.0000065560166,0.000038379105,0.0043324693,0.00000782372,0.00084617984],"genre_scores_gemma":[0.9952081,0.00014330405,0.000118200885,0.000047720412,0.000011727952,0.00007125145,0.004220058,0.0000058464616,0.00017381166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989361,0.00022563532,0.00018206009,0.00025152462,0.00026144343,0.00014329553],"domain_scores_gemma":[0.9971644,0.00038418834,0.0016509882,0.00020653271,0.0002575499,0.00033625134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016721713,0.00020729622,0.0005096423,0.0015249744,0.00040941522,0.00051659124,0.0004476042,0.00040859156,0.0015941254],"category_scores_gemma":[0.0028071483,0.00026943858,0.0006584834,0.0022151563,0.00021122253,0.0006809303,0.0005811916,0.00048344475,0.00040541068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012216045,0.000024800658,0.9990589,0.000007497415,0.000034127715,0.000026926304,0.000041645297,0.000024749315,0.00007426109,0.000008186496,0.00014669464,0.00042998494],"study_design_scores_gemma":[0.000012235319,0.00009783631,0.99912137,0.000007491672,0.000028218486,0.00016765993,0.00019403576,0.00010575935,0.000027875822,0.0000072948756,0.00022676731,0.000003381066],"about_ca_topic_score_codex":0.0062249782,"about_ca_topic_score_gemma":0.0068556634,"teacher_disagreement_score":0.0062249782,"about_ca_system_score_codex":0.00031040388,"about_ca_system_score_gemma":0.00057197554,"threshold_uncertainty_score":0.0123775005},"labels":[],"label_agreement":null},{"id":"W4313545427","doi":"10.1007/s40801-022-00348-w","title":"Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan","year":2023,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada; Eisai","keywords":"Lenvatinib; Medicine; Hepatocellular carcinoma; Internal medicine; Adverse effect; Observational study; Sorafenib; Gastroenterology","score_opus":0.08303397167619782,"score_gpt":0.3571824462241151,"score_spread":0.2741484745479173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313545427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99848986,0.00054751453,0.0001130656,0.00007719645,0.00000872325,0.00010372911,0.00033754285,0.0000033711208,0.00031903072],"genre_scores_gemma":[0.9984132,0.00026598587,0.000117197465,0.00015479863,0.000048623508,0.00011887311,0.0007714862,0.0000030344802,0.00010661145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972851,0.0009744314,0.000525006,0.0005159421,0.0004556025,0.00024387144],"domain_scores_gemma":[0.9898149,0.0012225838,0.00653897,0.0005458756,0.0009964022,0.00088130654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026229038,0.0003963541,0.0010580462,0.0006146852,0.000707067,0.0009637562,0.00038228516,0.0005271821,0.0011682555],"category_scores_gemma":[0.006139538,0.00037078225,0.0010436286,0.0011739217,0.0006278453,0.0009752603,0.00065536646,0.0010748467,0.0003093881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024314867,0.00062499865,0.9923229,0.00011670506,0.00031970584,0.00019631602,0.0003151785,0.000063615335,0.00028173314,0.000024371033,0.00033426916,0.0029687253],"study_design_scores_gemma":[0.00055621896,0.003953453,0.99175924,0.000039653434,0.00045285965,0.0007719405,0.00062039116,0.0005145547,0.00024025429,0.000042564083,0.0010175345,0.0000313462],"about_ca_topic_score_codex":0.0024264534,"about_ca_topic_score_gemma":0.0026131484,"teacher_disagreement_score":0.0026229038,"about_ca_system_score_codex":0.0011850868,"about_ca_system_score_gemma":0.0013668167,"threshold_uncertainty_score":0.013871372},"labels":[],"label_agreement":null},{"id":"W4379768697","doi":"10.1007/s40801-023-00376-0","title":"A Cross-Sectional Study of Patient Out-of-Pocket Costs for Antipsychotics Among Medicaid Beneficiaries with Schizophrenia","year":2023,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Medicaid; Cross-sectional study; Schizophrenia (object-oriented programming); Psychiatry; Medicine; Psychology; Health care","score_opus":0.17971684680191913,"score_gpt":0.4280976121435073,"score_spread":0.24838076534158815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379768697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986137,0.00008887207,0.000026426882,0.00006643172,0.000004056997,0.000014670992,0.0009569234,0.0000012907856,0.00022762187],"genre_scores_gemma":[0.9987369,0.00012351667,0.00006106122,0.000095299394,0.000010692439,0.00003242689,0.00078567554,0.0000012046156,0.00015317855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993413,0.00016492447,0.00012090183,0.00010267833,0.0001502014,0.00011988686],"domain_scores_gemma":[0.9975922,0.000276517,0.0015425014,0.000094221956,0.00022393778,0.00027057846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010260039,0.00022442751,0.00022924383,0.0010292925,0.0006139875,0.0005822226,0.00031527787,0.00047692098,0.0019908424],"category_scores_gemma":[0.0028519891,0.00038071713,0.0004934806,0.0012353978,0.00019685083,0.0008301684,0.0005438137,0.0007706232,0.00028200287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024781903,0.000050232604,0.9993855,0.0000047294566,0.000023011104,0.000015366082,0.000067115325,0.000008869262,0.000024394578,0.000007954519,0.00009653939,0.00029160242],"study_design_scores_gemma":[0.000003558088,0.000041702435,0.9993655,0.000007618814,0.000013521882,0.00007107135,0.0002972761,0.00007185127,0.000010593233,0.0000068608088,0.00010827129,0.0000022513848],"about_ca_topic_score_codex":0.021383815,"about_ca_topic_score_gemma":0.030640807,"teacher_disagreement_score":0.021383815,"about_ca_system_score_codex":0.00082143437,"about_ca_system_score_gemma":0.00057863665,"threshold_uncertainty_score":0.042518735},"labels":[],"label_agreement":null},{"id":"W4389009909","doi":"10.1007/s40801-023-00403-0","title":"Outcomes of a Medication Optimization Virtual Interdisciplinary Geriatric Specialist (MOVING) Program: A Feasibility Study","year":2023,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Toronto; Grand River Hospital; McMaster University; St. Michael's Hospital; Research Institute for Aging; Western University; Regional Municipality of Waterloo","funders":"Centre for Aging + Brain Health Innovation","keywords":"Polypharmacy; Medicine; Medical prescription; Deprescribing; Beers Criteria; Pharmacy; Confidence interval; Geriatrics; Emergency medicine; Family medicine; Internal medicine; Psychiatry; Nursing","score_opus":0.08937859802975036,"score_gpt":0.4479269365766704,"score_spread":0.35854833854692003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389009909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99898356,0.000023462904,0.000040308718,0.00003329965,0.0000029003436,0.000602767,0.0001043416,0.0000021733636,0.00020724146],"genre_scores_gemma":[0.99792826,0.00007061868,0.00053214305,0.00013380969,0.000022122176,0.00083269796,0.0002648063,0.0000019899176,0.00021357276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99647,0.0014858695,0.00026815795,0.0003401134,0.0007322782,0.0007036753],"domain_scores_gemma":[0.991968,0.0012338359,0.0026396415,0.00040582378,0.0013602626,0.0023924646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037749112,0.0005946247,0.000588955,0.00094900455,0.0013400792,0.0007336413,0.0006738119,0.0008838603,0.0012630029],"category_scores_gemma":[0.008215294,0.00048453858,0.0010465631,0.0010251577,0.001038588,0.0008984267,0.0013542984,0.00094715867,0.0002305542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009126434,0.03262765,0.9256053,0.00029750407,0.00021738875,0.00060319976,0.0031171085,0.00040134048,0.0011694916,0.00007244671,0.00042628296,0.026335983],"study_design_scores_gemma":[0.0011063524,0.057326153,0.93869907,0.00004300124,0.00008851373,0.00012900084,0.0016580315,0.00038526717,0.00018574596,0.000021953105,0.000324698,0.000032102853],"about_ca_topic_score_codex":0.051387075,"about_ca_topic_score_gemma":0.082857184,"teacher_disagreement_score":0.051387075,"about_ca_system_score_codex":0.0042349966,"about_ca_system_score_gemma":0.0061461665,"threshold_uncertainty_score":0.10217595},"labels":[],"label_agreement":null},{"id":"W4396798879","doi":"10.1007/s40801-024-00425-2","title":"Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United States","year":2024,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Treatment of Major Depression","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Depression (economics); Treatment-resistant depression; Health care; Ketamine; Medicine; Phase (matter); Psychiatry; Psychology; Intensive care medicine; Anxiety; Political science; Economics; Chemistry","score_opus":0.031367985124108336,"score_gpt":0.32910201810516154,"score_spread":0.2977340329810532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396798879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99725384,0.00034481374,0.000036227695,0.00013413014,0.000006028168,0.000011113848,0.0019251268,0.0000026458265,0.00028611318],"genre_scores_gemma":[0.99766374,0.00026180883,0.000073984105,0.00011109857,0.000009072822,0.000017771974,0.0017501652,0.0000017016382,0.00011068011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993998,0.00012696184,0.00013907216,0.00012472506,0.00011544318,0.00009404835],"domain_scores_gemma":[0.99826825,0.00014536174,0.00119368,0.000051558243,0.00013701402,0.00020414212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048526333,0.00018590358,0.0002885066,0.00076664187,0.00031516457,0.0005598942,0.00034414133,0.00033593492,0.0011866688],"category_scores_gemma":[0.0016319886,0.0002155265,0.0004475016,0.0012978412,0.00015115892,0.00047294775,0.00041933937,0.00052588753,0.00019548915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054054854,0.00003340456,0.9986771,0.0000081155895,0.000032874847,0.000017802498,0.00003201707,0.00002486465,0.00003080173,0.000006366343,0.0002016348,0.0008809524],"study_design_scores_gemma":[0.0000061425226,0.000042062726,0.99929714,0.000014610706,0.000014949217,0.00008626176,0.0001834729,0.0001513078,0.000019501043,0.00000878076,0.00017342545,0.000002304424],"about_ca_topic_score_codex":0.015255026,"about_ca_topic_score_gemma":0.027019512,"teacher_disagreement_score":0.015255026,"about_ca_system_score_codex":0.00064566435,"about_ca_system_score_gemma":0.00044102228,"threshold_uncertainty_score":0.030332506},"labels":[],"label_agreement":null},{"id":"W4399472268","doi":"10.1007/s40801-024-00432-3","title":"Association of Drug–Disease Interactions with Mortality or Readmission in Hospitalised Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Drugs - Real World Outcomes","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Flinders University; McGill University","keywords":"Meta-analysis; Medicine; Association (psychology); Disease; Systematic review; Gerontology; MEDLINE; Psychology; Internal medicine","score_opus":0.14369237111449087,"score_gpt":0.4471650787084417,"score_spread":0.30347270759395084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399472268","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033419814,0.99556726,0.0001975964,0.00011205573,0.00007345754,0.00022006252,0.00029951343,0.000011177508,0.000176961],"genre_scores_gemma":[0.101502344,0.8945357,0.0014141641,0.00059961365,0.00019069269,0.00094103155,0.00057263515,0.000013512295,0.0002302502],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9910711,0.0037184414,0.0029053579,0.0008593301,0.0011705494,0.00027528618],"domain_scores_gemma":[0.97544587,0.01814055,0.004285244,0.00045896388,0.0014311553,0.00023822884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011930004,0.0020345778,0.018544065,0.0066299015,0.0006511056,0.003357269,0.0020659883,0.0022431177,0.002744402],"category_scores_gemma":[0.033943746,0.0012920051,0.033393826,0.007424229,0.00062440214,0.0017815196,0.001520714,0.0017020426,0.00020833967],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012114801,0.00003376868,0.0049812086,0.57777727,0.40242887,0.00015172397,0.00009779758,0.00044811898,0.00012313141,0.00012771397,0.00056778896,0.012051225],"study_design_scores_gemma":[0.000426205,0.00026898054,0.005825026,0.06667085,0.9238029,0.00016634398,0.00006587139,0.00024170936,0.00011664737,0.00019272385,0.0021918009,0.00003100632],"about_ca_topic_score_codex":0.007990421,"about_ca_topic_score_gemma":0.01754678,"teacher_disagreement_score":0.018544065,"about_ca_system_score_codex":0.0031744656,"about_ca_system_score_gemma":0.0044257552,"threshold_uncertainty_score":0.06309265},"labels":[],"label_agreement":null},{"id":"W4401182078","doi":"10.1007/s40801-024-00428-z","title":"Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors","year":2024,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Janssen Scientific Affairs","keywords":"Medicine; Certolizumab pegol; Etanercept; Adalimumab; Golimumab; Psoriatic arthritis; Internal medicine; Discontinuation; Regimen; Ustekinumab; Oncology; Arthritis; Tumor necrosis factor alpha","score_opus":0.03223907047043479,"score_gpt":0.31396456753926755,"score_spread":0.28172549706883276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401182078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99240535,0.0016104501,0.0002948824,0.00014019602,0.000036670423,0.00024747447,0.003964253,0.000011110653,0.0012895665],"genre_scores_gemma":[0.99501204,0.0003195232,0.00027074272,0.0001688812,0.000055796903,0.0003247757,0.003591047,0.000004986683,0.00025227404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99307925,0.0036551042,0.0010855591,0.0008758356,0.0009787752,0.00032541942],"domain_scores_gemma":[0.9702917,0.010774834,0.014906562,0.0016789989,0.001277942,0.0010700393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007442491,0.00033120505,0.0008749311,0.0007549925,0.0003367611,0.001295074,0.0006245441,0.0008060433,0.003690145],"category_scores_gemma":[0.01637165,0.00020005905,0.0018137832,0.0010189416,0.00037277534,0.0009997993,0.00076528604,0.0010128017,0.00040353904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31848475,0.0045371125,0.59730554,0.0016929053,0.009708178,0.00010220324,0.000401757,0.0021837088,0.0010804437,0.00038704154,0.0026994164,0.0614169],"study_design_scores_gemma":[0.01868311,0.051332664,0.9097705,0.0004905239,0.0049129026,0.0005568025,0.00054480514,0.0061052595,0.0010734511,0.0007521871,0.005667117,0.00011069132],"about_ca_topic_score_codex":0.0009329701,"about_ca_topic_score_gemma":0.00084394286,"teacher_disagreement_score":0.007442491,"about_ca_system_score_codex":0.0009829941,"about_ca_system_score_gemma":0.0006882679,"threshold_uncertainty_score":0.039360106},"labels":[],"label_agreement":null},{"id":"W4406588954","doi":"10.1007/s40801-024-00478-3","title":"Mental Health-Related Disability Days and Costs Among Patients with Treatment-Resistant Depression Initiated on Esketamine Nasal Spray and Conventional Therapies in the USA","year":2025,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Treatment of Major Depression","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Nasal spray; Depression (economics); Treatment-resistant depression; Medicine; Mental health; Psychiatry; Nasal administration; Major depressive disorder; Pharmacology; Cognition","score_opus":0.014127845977609051,"score_gpt":0.2999420585609314,"score_spread":0.28581421258332235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406588954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651587,0.00033762588,0.000026689424,0.00011929803,0.0000060207094,0.000017928123,0.0025062389,0.0000021269138,0.00046818756],"genre_scores_gemma":[0.9964561,0.00038427586,0.000071585135,0.00015300067,0.000019341807,0.00003379337,0.0027216803,0.0000014670732,0.00015872257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995035,0.00010278876,0.0001113594,0.00007830638,0.000118980686,0.00008497523],"domain_scores_gemma":[0.99880826,0.00010525577,0.000758768,0.000025664578,0.000118718905,0.00018331443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033468546,0.00018092337,0.00034541896,0.0008325772,0.00033615003,0.00061495235,0.00023906332,0.0002866004,0.0011580951],"category_scores_gemma":[0.0014607746,0.00018102204,0.0005980731,0.0014911288,0.00016162822,0.0004201046,0.00050936814,0.0006851125,0.00017139298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022451527,0.00007526569,0.9956671,0.000027761596,0.00010651134,0.00006878076,0.000065391774,0.000051388994,0.00005817324,0.000023630855,0.000992474,0.0026389468],"study_design_scores_gemma":[0.0000246114,0.000079533755,0.9987307,0.0000250673,0.00004336647,0.00019067677,0.0002247268,0.00024685013,0.000023450679,0.000020249363,0.00038489036,0.0000057662983],"about_ca_topic_score_codex":0.023397043,"about_ca_topic_score_gemma":0.040695094,"teacher_disagreement_score":0.023397043,"about_ca_system_score_codex":0.00087519205,"about_ca_system_score_gemma":0.0005179067,"threshold_uncertainty_score":0.046521664},"labels":[],"label_agreement":null},{"id":"W4410896904","doi":"10.1007/s40801-025-00498-7","title":"Income-Based Disparities in Opioid Prescription Dispensing Among Public Drug Plan Beneficiaries in Canada from 2010 to 2018: A Population-Based and Sex-Stratified Retrospective Study","year":2025,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo","funders":"Health Canada; Substance Abuse and Mental Health Services Administration; Government of Canada","keywords":"Medical prescription; Medicine; Drug; Prescription drug; Retrospective cohort study; Population; Stratified sampling; Demography; Family medicine; Environmental health; Pharmacology; Internal medicine; Sociology","score_opus":0.010428237064049379,"score_gpt":0.2512439404970398,"score_spread":0.2408157034329904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410896904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9670406,0.0011269344,0.0002486728,0.00035297987,0.000020966718,0.00015583198,0.029047677,0.00003210363,0.0019741957],"genre_scores_gemma":[0.9900407,0.000593847,0.00030222145,0.00024574014,0.000014089622,0.000078964535,0.008214247,0.000011365878,0.0004988533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985262,0.00006649917,0.00012414016,0.00031345867,0.00051181385,0.00045783],"domain_scores_gemma":[0.9976301,0.0000738519,0.000624406,0.00010217381,0.0011654185,0.00040405017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008303741,0.0004318342,0.0006261763,0.0022271145,0.002573021,0.0011906226,0.0015309055,0.000426383,0.0014196566],"category_scores_gemma":[0.0018574958,0.00044450728,0.000858721,0.005863879,0.0006541265,0.00048561432,0.0010728366,0.00080290757,0.0002533377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031355143,0.00001711588,0.99760747,0.000029916517,0.00005217613,0.00003911693,0.00016963884,0.00003073132,0.000046454454,0.000040186267,0.0009622122,0.0009736998],"study_design_scores_gemma":[0.0000050326394,0.000016617589,0.99837625,0.000037505284,0.000046010235,0.00007160395,0.0004837528,0.00015972256,0.00004704275,0.000015240025,0.0007319875,0.000009256158],"about_ca_topic_score_codex":0.9832478,"about_ca_topic_score_gemma":0.9869338,"teacher_disagreement_score":0.019137979,"about_ca_system_score_codex":0.019137979,"about_ca_system_score_gemma":0.024419954,"threshold_uncertainty_score":0.13885641},"labels":[],"label_agreement":null}]}